Pharmacovigilance and COVID-19 : Medicines

Essential medicines

As of may 2022, over 524 million people worldwide have been diagnosed with COVID-19, according to the WHO dashboard. The pandemic has thus far claimed more than 6.2 million lives. Vaccination was having a substantial impact on case figures and hospitalizations in a number of high-income countries, but limited global access to vaccines means that many populations remain vulnerable.

The COVID-19 pandemic and the proliferation of research as well as misinformation has highlighted the need for trustworthy, accessible, and regularly updated guidance to put emerging findings into context and provide clear recommendations for clinical practice.